Bio
Dr. Svensson is an Associate Professor of Pathology at Stanford University and the Affinity Group Leader of the Stanford Diabetes Research Center. She received her Ph.D. from Lund University, Sweden and completed her postdoctoral studies at Harvard Medical School and the Dana-Farber Cancer Institute, Boston. Her laboratory studies the physiology and biochemistry of circulating factors and peptide hormones by using a combination of computational, proteomics, cellular, and physiological approaches. Her lab has made several findings in their pursuit to improve metabolic health, including the discovery of Isthmin as a circulating hormone that regulates glucose and lipid homeostasis. Dr. Svensson is a standing member of the NIDDK POMD study section, serves as an Associate Editor for Endocrine Reviews and is on the Editorial Board at Diabetes. She is also a co-founder of Merrifield Therapeutics. Her laboratory is supported by grants from the NIH, American Heart Association, Innovative Medicines Accelerator, SPARK, SDRC, MCHRI, Merck, Eli Lilly, and Pfizer.
